Antimicrobial resistance in Neisseria genorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1396-1403

  Fox, Kimberley K ^a   Knapp, Joan S ^b   Holmes, King K ^b   Hook III, Edward W ^b   Judson, Franklyn N ^b   Thompson, Sumner E ^b   Washington, John A ^b   Whittington, William L ^b  

^a NC DEHNR   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFICACY; GONORRHEA; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; UNITED STATES;

EID: 0030924223     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516472     Document Type: Article

References (14)

1. McCormack WM. Pelvic inflammatory disease. N Engl J Med 1994;330: 115-9.
2. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
3. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
4. Division of STD Prevention. Sexually transmitted disease surveillance, 1994. Atlanta: Centers for Disease Control and Prevention, 1995.
5. Cates W, Meheus A. Strategies for development of sexually transmitted diseases control programs. In: Holmes KK, Mardh PA, Sparling PF, et al., eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990:1023-30.
6. Centers for Disease Control. Penicillinase-producing Neisseria gonorrhocae. MMWR 1976; 25:261.
7. Faruki H, Kohmescher RN, McKinney WP, Sparling PF. A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med 1985;313:607-11.
8. Rice RJ, Biddle JW, JeanLouis YA, DeWitt WE, Blount JH, Morse SA. Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984. J Infect Dis 1986:153:340-5.
9. Whittington WL, Knapp JS. Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States. Sex Transm Dis 1988; 15: 202-10.
10. Knapp JS, Zenilman JM, Biddle JW, et al. Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmidmediated resistance to tetracycline. J Infect Dis 1987; 155:819-22.
11. Centers for Disease Control. Policy guidelines for the detection, management, and control of antibiotic-resistant strains of Neisseria gonorrhoeae. MMWR CDC Surveill Summ 1987;36(no. S5).
12. Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. MMWR CDC Surveill Summ 1989;38(no. S8).
13. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993; 42(no. RR-14).
14. Putnam SD, Lavin BS, Stone JR, Oldfield EC, Hooper DG. Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia. J Clin Microbiol 1992; 30:974-80.